Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06422156
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-03-17
Brief Title:
SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer
Sponsor:
Peking University Third Hospital
Organization:
Peking University Third Hospital
Organization Data
Organization:
Peking University Third Hospital
Class:
OTHER
Study ID:
M2023639
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Third Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Biotech Pharmaceutical Co Ltd | OTHER |